Pfizer is testing an mRNA flu shot. Getty ImagesKey FactsPfizer said it had dosed the first participants in a study designed to test the mRNA-based flu vaccine it developed with German biotech firm BioNTech, the same company it worked with for its Covid-19 vaccine. The U.S.-based study—an early-stage Phase 1 clinical trial—will evaluate the safety and immune responses compared to another flu vaccine approved by the Food and Drug Administration. Sanofi and Moderna are also testing flu shots built using mRNA. TangentDespite promising results from early-to-mid-stage clinical trials, a spokesperson for French pharma firm Sanofi confirmed to Forbes the company would not be moving forward with its mRNA Covid-19 vaccine, as first reported by Bloomberg.

Source: Forbes September 28, 2021 09:56 UTC